Clinical Trial: To Evaluate the Efficacy and Safety Aliviador Compared to Gelol in Patients With Contusions, Sprains, Trauma and Muscle Injury.

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Multicenter, Randomized, Double-blind Trial to Evaluate the Efficacy and Safety Aliviador Compared to Gelol in the Relief in Patients With Contusons, Sprains,Trauma and Muscle Injury.

Brief Summary: Multicenter, randomized, double-blind trial, to evaluate the efficacy and safety Aliviador compared to Gelol in the relief of signs and symptoms in patients with contusions, sprains, trauma and muscle injury start with less than 24 hours or patients of myalgia, myofascial pain and tendinitis.

Detailed Summary:
Sponsor: Laboratorio Brasileiro de Biologia

Current Primary Outcome: To evaluate the efficacy in reducing signs and symptoms Aliviador compared to Gelol. [ Time Frame: two days ]

To evaluate the efficacy in reducing signs and symptoms Aliviador compared to Gelol in patients with contusions, sprains, muscle injury and trauma, starting less than 24 hours or patients with muscle pain, myofascial pain and tendinitis.


Original Primary Outcome: Same as current

Current Secondary Outcome: To evaluate the tolerability use Aliviador compared to Gelol. [ Time Frame: two days ]

To evaluete the tolerability use Aliviador compared to Gelol in patients with contusions, sprains, muscle injury and traumas starting less than 24 hours or patients with myalgia, myofascial pain and tendinitis.


Original Secondary Outcome: Same as current

Information By: Laboratorio Brasileiro de Biologia

Dates:
Date Received: April 1, 2010
Date Started: June 2010
Date Completion: August 2010
Last Updated: April 15, 2010
Last Verified: February 2010